Skip to content

Potentially Inappropriate Prescription Associated to Multimorbidity

Potentially Inappropriate Prescription Associated to Multimorbidity, Using the Explicit STOPP-START (Screening Tool of Older Persons' Potentially Inappropriate Prescriptions/Screening Tool to Alert Doctors to the Right Treatment) Criteria

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02830425
Acronym
PIMyC
Enrollment
740
Registered
2016-07-12
Start date
2016-01-31
Completion date
2019-12-31
Last updated
2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Disease

Keywords

Multimorbidity, Polypharmacy, Appropriateness, STOPP, START

Brief summary

A prospective multicenter cohort study in 5 hospitals in Spain will be initiated in 2016. Objectives: 1. To estimate and describe patterns of multimorbidity and polypharmacy in patients over 64 admitted for a chronic disease exacerbation. 2. To analyze the potentially inappropriate prescribing (PPI) drugs according to STOPP / START (SS) criteria. 3. To evaluate the relationship between multimorbidity and PPI and adverse medication (RAM) preventable reaction. The cohort will include 800 patients \>64 years admitted in internal medicine and / or geriatric department of 5 hospitals of the National Health Service. Application of the SS criteria (released in 2015) on admission and at discharge, and collection of demographic and clinical variables including comorbidities, baseline chronic medication, geriatric syndromes, functional capacity and RAM. Descriptive analysis and bivariate parametric or nonparametric tests will be applied to analyze relationship between morbidity, polypharmacy, SS criteria and RAM. Intraobserver agreement will be assessed for SS criteria. Multiple regression techniques will be applied, where the dependent variable will be the PPI or the RAM.

Interventions

OTHERNo intervention

Sponsors

Fondo de Investigacion Sanitaria
CollaboratorOTHER
Hospital del Mar
CollaboratorOTHER
Hospital de Galdakao
CollaboratorOTHER
Consorci Hospitalari de Vic
CollaboratorOTHER
Hospital Universitario de Canarias
CollaboratorOTHER
Corporacion Parc Tauli
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient admitted to the Internal Medicine or Geriatrics department * Admitted to hospital because of an exacerbation of any previous chronic condition

Exclusion criteria

* Terminal ill patients at admission * Patients with lower forecast life than 1 year * Patient admitted to the hospital only because an acute problem * In patient home care

Design outcomes

Primary

MeasureTime frame
Percentage of patients with Potentially inappropriate medication, according to STOPP-START explicit criteriaAt study entry

Secondary

MeasureTime frameDescription
Percentage of patients with Potentially inappropriate medication, according to STOPP-START explicit criteriaThrough study completion, an average of 2 years
Percentage of patients with polypharmacyAt study entryPolypharmacy=more than 5 chronic medications
Patients with any treatment-related adverse events (ADR), according to the Wills & Brown classificationThrough study completion, an average of 2 years
Percentage of different Patterns of multimorbidity in chronic patients, according to clusters or associations of different chronic conditionsAt study entry

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026